| |
| |
|
| Insider
Information: |
Kirk Randal J |
| Relationship: |
10% Owner |
| City: |
Radford |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
3,684,697 |
|
|
Indirect Shares
|
67,796,291 |
|
|
| Direct
Value |
$179,101,866 |
|
|
|
Indirect Value
|
$415,833,338 |
|
|
| Total
Shares |
71,480,988 |
|
|
| Total
Value |
$594,935,205 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
14
|
0
|
|
Stock
price went up :
|
7
|
0
|
| Stock
price went down : |
7
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 48.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGEN |
Precigen Inc |
Director |
– • • |
2022-01-04 |
4 |
OE |
$0.00 |
$0 |
I/I |
3,444 |
18,741,568 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • • |
2022-03-25 |
4 |
OE |
$0.00 |
$0 |
I/I |
32,425 |
19,037,059 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • • |
2022-10-05 |
4 |
A |
$0.00 |
$0 |
I/I |
26,374 |
1,015,626 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • • |
2022-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,028,089 |
1,015,604 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • • |
2023-02-22 |
4 |
OE |
$0.00 |
$0 |
I/I |
123,152 |
31,252,316 |
0 |
- |
|
| PGEN |
Precigen Inc |
|
– • • |
2024-03-09 |
4 |
OE |
$0.00 |
$0 |
I/I |
213,675 |
32,051,461 |
0 |
- |
|
| PGEN |
Precigen Inc |
|
– • • |
2024-05-02 |
4 |
A |
$0.00 |
$0 |
I/I |
14,981,883 |
6,085,471 |
0 |
- |
|
| PGEN |
Precigen Inc |
|
– • • |
2024-05-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(19,447,371) |
0 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-09-11 |
4 |
B |
$2.54 |
$8,128 |
I/I |
3,200 |
564,300 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-08-18 |
4 |
B |
$2.42 |
$8,470 |
I/I |
3,500 |
174,300 |
1.5 |
- |
|
| PRPO |
Precipio Inc |
10% Owner |
– – • |
2018-08-28 |
4 |
S |
$0.41 |
$10,086 |
I/I |
(24,600) |
27,151 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-08-23 |
4 |
B |
$2.49 |
$16,683 |
I/I |
6,700 |
211,100 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-08-21 |
4 |
B |
$2.46 |
$30,750 |
I/I |
12,500 |
186,800 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-12-04 |
4 |
B |
$2.86 |
$32,890 |
I/I |
11,500 |
792,300 |
1.5 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2016-08-17 |
4 |
OE |
$2.65 |
$32,911 |
I/I |
11,828 |
5,259,404 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-09-07 |
4 |
B |
$2.51 |
$37,650 |
I/I |
15,000 |
530,600 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2012-06-05 |
4 |
B |
$7.48 |
$40,863 |
I/I |
5,463 |
331,394 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-08-22 |
4 |
B |
$2.46 |
$43,296 |
I/I |
17,600 |
204,400 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-09-06 |
4 |
B |
$2.56 |
$44,288 |
I/I |
17,300 |
515,600 |
1.5 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-08-22 |
4 |
B |
$12.30 |
$49,348 |
I/I |
4,012 |
512,762 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2013-10-15 |
4 |
OE |
$4.94 |
$49,400 |
D/D |
10,000 |
3,480,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-09-14 |
4 |
B |
$2.50 |
$50,000 |
I/I |
20,000 |
678,300 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-09-12 |
4 |
B |
$2.58 |
$51,600 |
I/I |
20,000 |
584,300 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-08-29 |
4 |
B |
$2.60 |
$59,800 |
I/I |
23,000 |
498,300 |
1.5 |
- |
|
| PGEN |
Precigen Inc |
Executive Chairman |
• • • |
2020-09-24 |
4 |
A |
$3.50 |
$74,998 |
I/I |
21,428 |
13,517,050 |
0 |
- |
|
271 Records found
|
|
Page 3 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
